Febuxostat, known by the brand name Uloric, is an XOI meant to treat gout. Approved by the FDA in 2009, it is manufactured by the Japanese pharmaceutical company Takeda Pharmaceuticals. Side effects include chest pain, breathing difficulties, irregular heartbeats, numbness on one side of the body, nausea, trouble speaking, and severe headaches.